| 发明名称 |
Pharmaceutical formulation |
| 摘要 |
A solid, oral controlled release pharmaceutical dosage form has a water-soluble active ingredient dispersed in a matrix and releases the active ingredient at such a rate upon administration that the median tmax is 2.5 to 6 hours and the ratio of mean Cmax to mean plasma level of the active ingredient at 24 hours is in the range of 1.5 to 3.5.
|
| 申请公布号 |
US8506998(B2) |
申请公布日期 |
2013.08.13 |
| 申请号 |
US20060640749 |
申请日期 |
2006.12.18 |
| 申请人 |
MILLER RONALD BROWN;LESLIE STEWART THOMAS;MALKOWSKA SANDRA THERESE ANTOINETTE;PRATER DEREK ALLAN;KNOTT TREVOR JOHN;MOHAMMAD HASSAN;EURO-CELTIQUE S.A. |
发明人 |
MILLER RONALD BROWN;LESLIE STEWART THOMAS;MALKOWSKA SANDRA THERESE ANTOINETTE;PRATER DEREK ALLAN;KNOTT TREVOR JOHN;MOHAMMAD HASSAN |
| 分类号 |
A61K9/20;A61K9/16;A61K9/22;A61K9/26;A61K9/54;A61K31/485 |
主分类号 |
A61K9/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
